Clarenta Group Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 350

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

  • Investments
  • 2

Clarenta Group General Information

Description

Provider of clinical research services intended to support the development of medical treatments. The company offers clinical trial services, phase I research, regulatory services, data management services, biostatistics services and functional service provider solutions, enabling pharmaceutical and biotechnology firms to manage clinical trials from phase I to IV.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 69, Bulgaria Boulevard Floor 7
  • Tower (Building) B
  • Sofia, 1404
  • Bulgaria
+359 02
Primary Industry
BPO/Outsource Services
Other Industries
Laboratory Services (Healthcare)
Corporate Office
  • 69, Bulgaria Boulevard Floor 7
  • Tower (Building) B
  • Sofia, 1404
  • Bulgaria
+359 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clarenta Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Clarenta Group‘s full profile, request access.

Request a free trial

Clarenta Group Patents

Clarenta Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3370607-A1 Method and device for measurement of exhaled respiratory gas temperature from specific regions of the airway Inactive 20-Nov-2015
GB-201520496-D0 Method and device for measurement of exhaled respiratory gas temperature from specific regions of the airway Inactive 20-Nov-2015
GB-2544541-A Method and device for measurement of exhaled respiratory gas temperature from specific regions of the airway Inactive 20-Nov-2015
US-20180325421-A1 Method and device for measurement of exhaled respiratory gas temperature from specific regions of the airway Inactive 20-Nov-2015
WO-2017085165-A1 Method and device for measurement of exhaled respiratory gas temperature from specific regions of the airway Inactive 20-Nov-2015 A61B5/01
To view Clarenta Group’s complete patent history, request access »

Clarenta Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Clarenta Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Clarenta Group‘s full profile, request access.

Request a free trial

Clarenta Group Investments (2)

Clarenta Group’s most recent deal was a Buyout/LBO with Leads To Development. The deal was made on 30-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Leads To Development 30-Sep-2026 Buyout/LBO Other Healthcare Services
Ilife Consulting 22-May-2025 Buyout/LBO Consulting Services (B2B)
To view Clarenta Group’s complete investments history, request access »

Clarenta Group Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Ilife Consulting Paris, France 2013
Leads To Development Paris, France 2009

Clarenta Group FAQs

  • When was Clarenta Group founded?

    Clarenta Group was founded in 1997.

  • Where is Clarenta Group headquartered?

    Clarenta Group is headquartered in Sofia, Bulgaria.

  • What is the size of Clarenta Group?

    Clarenta Group has 350 total employees.

  • What industry is Clarenta Group in?

    Clarenta Group’s primary industry is BPO/Outsource Services.

  • Is Clarenta Group a private or public company?

    Clarenta Group is a Private company.

  • What is Clarenta Group’s current revenue?

    The current revenue for Clarenta Group is .

  • Who are Clarenta Group’s investors?

    EdgeCap Partners has invested in Clarenta Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process